The
New
Health
Institute
Our latest
The Mission
We are here to engage in education of the general public regarding evidence-based best practices for mental health treatment and encourage the safe integration of new mental health treatments into the healthcare system.
Our vision is clear. To become the definitive voice demystifying alternative and lifestyle medicines through safe, evidence-based, and innovative content using Ai and Data.
The New Health Institute is a U.S.-based 501(c)(3) nonprofit organization.
The ProblemPsychedelics content faces social stigma and algorithmic shadow bans – limiting visibilityand mainstream access.
Anne Philippi
After 15 years in high-profile journalism covering Hollywood and tech for GQ, VOGUE, and VANITY FAIR, Anne Philippi had a transformative experience with psychedelics. In 2020, she founded "The New Health Club Podcast," the first lifestyle-inspired psychedelic podcast, supported by leaders like Dr. Bronner’s and Christian Angermayer. The show connected her with top experts and expanded her network and became the first lifestyle podcast in in the psychedelic field. She speaks at conferences such as Horizons and Psychedelic Science, advocating for de-stigmatizing psychedelic medicine. In 2025, she launched The New Health Institute, a US-based nonprofit dedicated to redefining cultural narratives around psychedelics and increasing visibility and access amid social stigma and shadow bans. She remains deeply involved in the global psychedelic ecosystem and creating content beyond the industry.

Board Members

A Managing Partner of JLS Fund, Lindsay Hoover has over 20 years of experience in finance, including investment banking, strategic advisory and consulting, and principal investing. She is also Co-Founder and Board Member of ImmersiveWorlds, an augmented and virtual reality commerce platform targeting wellbeing through behavioral modification.

William Leonard Pickard is a former research associate in neurobiology at Harvard Medical School, Harvard fellow in drug policy at the Harvard Kennedy School of Government, and Deputy Director of the Drug Policy Analysis Program at UCLA. His 1996 prediction of the fentanyl epidemic was published by RAND in The Future of Fentanyl and Other Synthetic Opioids.A highly influential figure in the realm of scientific research, Leonard Pickard is recognized for his pioneering work in chemistry and psychedelic research. His efforts have advanced understanding of neurochemistry and contributed to the resurgence of interest in the therapeutic and spiritual potentials of psychedelics.

William Welch has 30-plus years of experience as a business transformation leader specializing in building stakeholder-centric business processes, from guiding your organization through executive vision to full execution. He specializes in reversing inefficiencies, introducing best practices, and understanding key stakeholders. The key component for William’s success is caring for both the people and the business.
From the Peace Corps in Lesotho, Africa, to building the Texas Children’s Health Insurance Program, William has used his Master’s in International Agriculture and Rural Development from Cornell to build communities that serve the environment and the most disadvantaged. William’s specialties are enabling and maintaining operations for leaders focused on vision and fundraising and developing staff who haven’t had the privileges of education and business experience. William has successfully supported many nonprofits in navigating all of the administrative and bureaucratic matters so the nonprofit leaders can concentrate on saving our communities.

Rick Doblin, Ph.D., is the visionary Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a pioneering organization dedicated to transforming the understanding and use of psychedelics and marijuana. With a Ph.D. in Public Policy from Harvard Kennedy School, his groundbreaking research included the regulation of psychedelic medicines and a survey on oncologists' preferences for cannabis-based nausea treatments. An esteemed scholar, his undergraduate thesis extended the transformative Good Friday Experiment by 25 years, and he conducted a 34-year follow-up to Timothy Leary’s famed Concord Prison Experiment. Studying under Dr. Stanislav Grof, he became one of the first certified Holotropic Breathwork practitioners. His lifelong mission is to establish rigorous legal frameworks that enable the therapeutic and personal growth applications of psychedelics and cannabis. Since founding MAPS in 1986, he has been at the forefront of advancing science, policy, and education in this field. Rick resides in Boston with his family and continues to lead the charge in humanizing and legitimizing psychedelic-assisted therapies.

David S. Blum serves as of counsel in Montgomery McCracken's Business Department and a past Chair of the firm’s Diversity Committee for five years. He represents property owners, developers, investors and institutions in acquisition and sales transactions, debt and equity financing, leasing and condominium creation, and in matters involving property ownership, development and management. He routinely represents multifamily, commercial, and retail projects.In the area of real estate finance, David represents regional banks, private finance companies, and conduit lenders in structuring, negotiating, and closing hundreds of real estate acquisition and construction loans, including loans to finance condominium and shopping center developments, life care and continuing care facilities. He also represents multifamily, commercial and retail owners and developers in connection with construction and permanent financing transactions, including transactions involving tax increment financing (TIFs) for public-private projects, tax exempt financing and securitized loan transactions. He also has extensive experience in loan workouts and restructurings and in the acquisition and disposition of real estate asset portfolios involving distressed properties and debt.David’s practice also involves representation of institutional, entrepreneurial clients, including architects, brokers, and nonprofit organizations in transactions involving the creation of corporations, partnerships and other business enterprises, purchase and sale of real estate and business assets, development and lease of office and programmatic space, resolution of lease disputes, and analysis of zoning, code compliance, and assessment issues.David received his J.D. from University of California's Berkeley School of Law and graduated, magna cum laude, with a B.S. from Georgetown University.
Advisors

Gigi Danziger is an American entrepreneur and investor. She co-founded The Spark of Hudson, a community learning center that launched HudsonUP, the first small-city universal basic income (UBI) pilot in the U.S. She also co-founded Wally Farms, a “farm of the future” and innovation hub for climate solutions.Her dedication to innovative solutions has improved countless lives through impactful projects in education, health, and community development.

Albert Wenger is a partner at Union Square Ventures (USV). Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). Albert is the author of the book The World After Capital. On his blog Continuations he writes about technology, science, philosophy and more. Albert graduated from Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.

Tom Florio is a respected visionary with a remarkable track record of elevating iconic titles/brands to record levels of profitability. He is an expert in producing content that drives commerce while improving the value proposition of global enterprises. Known as a digital pioneer, he expanded brands through diverse media platforms, generating e-commerce, video, and branded content. Tom Florio has a history of managing brilliant, world-renowned talent while strengthening an impressive professional network of editors, advertisers, and agencies.
The first Psychedelic
Foundation that’s AI-first.
Content Strategy for Future Success
Positioning psychedelics within a lifestyle-driven framework: using culture as the Trojan horse to reach and engage mainstream audiences. Refined guest strategy: Invite compelling voices from diverse categories, united by a common denominator their mental health journeys and experiences with psychedelics.

Featuring leading voices in psychedelic science, therapy, and culture – from pioneering researchers to visionary artists and entrepreneurs.
Podcast
Listened to in Europe, the US, and beyond – connecting communities worldwide.
The New Health Club Show is a podcast by Anne Philippi about the role of psychedelics in therapy and mental health, featuring experts from medicine, research, and culture. It explores safe and legal ways these substances may support healing and personal growth.
